- Home
- BAP vs BAX Comparison
BAP vs BAX Comparison
Compare BAP & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAP
- BAX
- Stock Information
- Founded
- BAP 1889
- BAX 1931
- Country
- BAP Peru
- BAX United States
- Employees
- BAP N/A
- BAX N/A
- Industry
- BAP Major Banks
- BAX Medical/Dental Instruments
- Sector
- BAP Finance
- BAX Health Care
- Exchange
- BAP Nasdaq
- BAX Nasdaq
- Market Cap
- BAP 17.7B
- BAX 15.7B
- IPO Year
- BAP 1995
- BAX N/A
- Fundamental
- Price
- BAP $227.25
- BAX $30.66
- Analyst Decision
- BAP Hold
- BAX Buy
- Analyst Count
- BAP 4
- BAX 8
- Target Price
- BAP $211.00
- BAX $37.25
- AVG Volume (30 Days)
- BAP 295.9K
- BAX 3.4M
- Earning Date
- BAP 08-07-2025
- BAX 08-05-2025
- Dividend Yield
- BAP 4.84%
- BAX 2.19%
- EPS Growth
- BAP 15.58
- BAX N/A
- EPS
- BAP 19.76
- BAX N/A
- Revenue
- BAP $5,114,481,827.00
- BAX $10,771,000,000.00
- Revenue This Year
- BAP $25.40
- BAX $8.05
- Revenue Next Year
- BAP $6.06
- BAX $4.19
- P/E Ratio
- BAP $11.44
- BAX N/A
- Revenue Growth
- BAP 14.82
- BAX 15.36
- 52 Week Low
- BAP $153.27
- BAX $26.25
- 52 Week High
- BAP $228.69
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- BAP 70.55
- BAX 56.03
- Support Level
- BAP $218.59
- BAX $30.06
- Resistance Level
- BAP $226.85
- BAX $31.76
- Average True Range (ATR)
- BAP 4.33
- BAX 0.65
- MACD
- BAP 0.25
- BAX 0.09
- Stochastic Oscillator
- BAP 90.39
- BAX 75.14
About BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.